Predicine Appoints Dr. Dennis Merkle As Chief Executive Officer Of Predicine Europe And Global Head Of Biopharma Business

Published by
The Street

By PR Newswire SILICON VALLEY, Calif., Jan. 4, 2022 /PRNewswire/ — Predicine, a global molecular insights company, announced today that it has appointed Dennis Merkle, PhD, MBA, as its new Chief Executive Officer (CEO) for Predicine Europe as well as its Global Head of Biopharma Business. Dr. Merkle moves into the role after leading the oncology development strategy, alliance management and biorepository teams at Invitae, which he joined as part of the acquisition of ArcherDx, where he was Senior Vice President of corporate development. Known for his strategic leadership across commercial and…

Read More

Recent Posts